Consensus of Expert Recommendations for the Safe Administration of Brolucizumab in Neovascular Age-related Macular Degeneration. [PDF]
Song JR +14 more
europepmc +1 more source
Drug-induced immune-mediated uveitis: a real-world pharmacovigilance analysis using FAERS and JADER databases. [PDF]
Xu S +6 more
europepmc +1 more source
Laser Speckle Flowgraphy (LSFG) in Age-Related Macular Degeneration and Diabetic Retinopathy: A Systematic Review of Recent Literature. [PDF]
Bellucci C +4 more
europepmc +1 more source
Multimodal Imaging to Assess Disease Activity and Predict Fluid Resolution in Patients with wAMD Treated with Brolucizumab: The IMAGINE Study. [PDF]
Lupidi M +8 more
europepmc +1 more source
Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease? [PDF]
Chia, Mark A, Keane, Pearse A
core
Brolucizumab efficacy and safety single-arm descriptive trial in patients with persistent diabetic macular edema (BEST study): protocol for a single-centre, open-label, single-arm clinical trial in China. [PDF]
Huang Z +12 more
europepmc +1 more source
Effectiveness and Safety of Intravitreal Brolucizumab for Diabetic Macular Edema After Vitrectomy: A Before-and-After Study at a Specialized Center in Japan. [PDF]
Saito K, Akiyama H.
europepmc +1 more source
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular Degeneration. [PDF]
Yoneyama S +7 more
europepmc +1 more source
Model-based pharmacoeconomic analysis of anti-VEGF strategies for neovascular age-related macular degeneration: a value-based comparison of real-world administration approaches. [PDF]
Gismero Moreno SM +4 more
europepmc +1 more source
Therapeutic approaches to diabetic macular edema assessed using optical coherence tomography and optical coherence tomography angiography. [PDF]
Dadkhah PA +16 more
europepmc +1 more source

